Clinical trial

Effects of Erythropoietin on Cognition and Neural Activity in Mood Disorders

NCT03315897

Drugs and interventions used in this trial

2 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

DRUG · Unmapped registry intervention Erythropoietin Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention Saline Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

Effects of Erythropoietin on Cognition and Neural Activity in Mood Disorders

Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE2

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2017-07-05

PhasePHASE2

Conditions

Bipolar Disorderverified · MONDO: bipolar disorder

Cognitive Impairmentunresolved

Unipolar Depressionverified · MONDO: major depressive disorder

Interventions

ErythropoietinDRUG

SalineDRUG

Sponsors & collaborators

Lars Vedel Kessinglead sponsor

Mental Health Centre Copenhagen, Bispebjerg and Frederiksberg Hospitalcollaborator

Lundbeck Foundationcollaborator

Mapped research locations

CopenhagenDenmark1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT03315897 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.